Molecular mechanisms of Alzheimer’s disease: From therapeutic targets to promising drugs

Cites (240)

Items 201–239 of 239

1. Positive Allosteric Modulation of Alpha7 Nicotinic Acetylcholine Receptors Transiently Improves Memory but Aggravates Inflammation in LPS-Treated Mice
   Olena Lykhmus, Olena Kalashnyk, Kateryna Uspenska, Maryna Skok · 2020 · Frontiers in Aging Neuroscience
2. The Neuroprotective Effects of SIRT1 in Mice Carrying the APP/PS1 Double-Transgenic Mutation and in SH-SY5Y Cells Over-Expressing Human APP670/671 May Involve Elevated Levels of α7 Nicotinic Acetylcholine Receptors
   Kun Cao, Yang‐Ting Dong, Jie Xiang, Yi Xu, Yi Li, Hui Song, Wenfeng Yu, Xiaolan Qi, Zhi-Zhong Guan · 2019 · Aging
3. Computational design and evaluation of β‐sheet breaker peptides for destabilizing Alzheimer's amyloid‐β 42 protofibrils
   Suniba Shuaib, Simranjeet Singh Narang, Deepti Goyal, Bhupesh Goyal · 2019 · Journal of Cellular Biochemistry
4. Pharmacological Strategies to Improve Dendritic Spines in Alzheimer’s Disease
   Miren Ettcheto, Oriol Busquets, Amanda C. Cano, Elena Sánchez‐López, Patrícia Regina Manzine, Triana Espinosa-Jiménez, Ester Verdaguer, Francesc Xavier Sureda, Jordi Olloquequi, Ruben Dario Castro-Torres et al. · 2020 · Journal of Alzheimer s Disease
5. β-Sheet Breaker Peptide-HPYD for the Treatment of Alzheimer's Disease: Primary Studies on Behavioral Test and Transcriptional Profiling
   Weiying Liu, Feng-Xian Sun, Moxin Wan, Fang Jiang, Xiangyu BO, Laixiang Lin, Hua Tang, Shumei Xu · 2018 · Frontiers in Pharmacology
6. Genistein and Galantamine Combinations Decrease β-Amyloid Peptide (1–42)–Induced Genotoxicity and Cell Death in SH-SY5Y Cell Line: an In Vitro and In Silico Approach for Mimic of Alzheimer’s Disease
   Willian Orlando Castillo Ordoñez, Nilza Velasco Palomino, Catarina Satie Takahashi, Silvana Giuliatti · 2020 · Neurotoxicity Research
7. Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice
   Yaowei Huang, Wei Huang, Yingwei Huang, Pingping Song, Melanie Zhang, Han‐Ting Zhang, Suyue Pan, Yafang Hu · 2020 · Journal of Alzheimer s Disease
8. The neuroprotective effects of phosphocreatine on Amyloid Beta 25–35-induced differentiated neuronal cell death through inhibition of AKT /GSK-3β /Tau/APP /CDK5 pathways in vivo and vitro
   Jie Ai, Hongyan Wang, Peng Chu, Abdullah Shopit, Mengyue Niu, Nisar Ahmad, Tsehaye Tesfaldet, Fu Han Wang, Jia Ni Fang, Xiaodong Li et al. · 2020 · Free Radical Biology and Medicine
9. Impaired object-location learning and recognition memory but enhanced sustained attention in M2 muscarinic receptor-deficient mice
   Carola Romberg, Susan J. Bartko, Jürgen Wess, Lisa M. Saksida, Timothy J. Bussey · 2018 · Psychopharmacology
10. Modulation of the MAPKs pathways affects Aβ-induced cognitive deficits in Alzheimer’s disease via activation of α7nAChR
    Ke-Wei Chang, Hang-Fan Zong, Mohammad Yasir Rizvi, Kaige Ma, Wanying Zhai, Meng Wang, Weina Yang, Shengfeng Ji, Yi‐Hua Qian · 2020 · Neurobiology of Learning and Memory
11. Enhancing α-secretase Processing for Alzheimer’s Disease—A View on SFRP1
    Bor Luen Tang · 2020 · Brain Sciences
12. Protein kinases A and C regulate amyloid-β degradation by modulating protein levels of neprilysin and insulin-degrading enzyme in astrocytes
    Naoki Yamamoto, Mitsuki Nakazawa, Naho Nunono, Nao Yoshida, Ayako Obuchi, Mamoru Tanida, Kenji Suzuki, Yuri Ikeda‐Matsuo, Kazuya Sobue · 2020 · Neuroscience Research
13. Exploring the role of mitochondrial proteins as molecular target in Alzheimer’s disease
    Swati Chadha, Tapan Behl, Aayush Sehgal, Arun Kumar, SIMONA GABRIELA BUNGAU · 2020 · Mitochondrion
14. Enhancing the binding of the β-sheet breaker peptide LPFFD to the amyloid-β fibrils by aromatic modifications: A molecular dynamics simulation study
    Pavan Krishna Kanchi, Ashok Kumar Dasmahapatra · 2021 · Computational Biology and Chemistry
15. Pharmacological Characterization of the Novel and Selective α7 Nicotinic Acetylcholine Receptor–Positive Allosteric Modulator BNC375
    Xiaohai Wang, Christopher Daley, Vanita Gakhar, Henry S. Lange, Joshua D. Vardigan, Michelle S. Pearson, Xiaoping Zhou, Lee Warren, Corin O. Miller, Michelle Belden et al. · 2020 · Journal of Pharmacology and Experimental Therapeutics
16. RPS23RG1 modulates tau phosphorylation and axon outgrowth through regulating p35 proteasomal degradation
    Dongdong Zhao, Yunqiang Zhou, Yuanhui Huo, Jian Meng, Xiaoxia Xiao, Linkun Han, Xian Zhang, Hong Luo, Dan Can, Hao Sun et al. · 2020 · Cell Death and Differentiation
17. Sirt‐1 Regulates Physiological Process and Exerts Protective Effects against Oxidative Stress
    Lei Liu, Guangyuan Xia, Peifan Li, Yiming Wang, Qian Lei Zhao · 2021 · BioMed Research International
18. Cognitive improvement and synaptic deficit attenuation by a multifunctional carbazole-based cyanine in AD mice model through regulation of Ca2+/CaMKII/CREB signaling pathway
    Chen Chen, Di Xu, Zhong-Hao Zhang, Shi-Zheng Jia, Xian-Chun Cao, Yubin Chen, Guo-Li Song, Man Shing Wong, Hung‐Wing Li · 2020 · Experimental Neurology
19. Delta-secretase triggers Alzheimer’s disease pathologies in wild-type hAPP/hMAPT double transgenic mice
    Zhourui Wu, Xia Liu, Liming Cheng, Keqiang Ye · 2020 · Cell Death and Disease
20. Neuroprotective effects of carbenoxolone against amyloid-beta 1–42 oligomer-induced neuroinflammation and cognitive decline in rats
    Sheetal Sharma, Avneet Saini, Bimla Nehru · 2021 · NeuroToxicology
21. ADAM10 and ADAM17 are degraded by lysosomal pathway via asparagine endopeptidase
    Xingyu Zhang, Li Tang, Zhentao Zhang · 2020 · Biochemical and Biophysical Research Communications
22. Sigma-2 receptor as a potential therapeutic target for treating central nervous system disorders
    Kazuki Terada, Keisuke Migita, Yukari Matsushima, Chiaki Kamei · 2019 · Neural Regeneration Research
23. Modified Snake α-Neurotoxin Averts β-Amyloid Binding to α7 Nicotinic Acetylcholine Receptor and Reverses Cognitive Deficits in Alzheimer’s Disease Mice
    Gennadiy Fonar, Baruh Polis, Dev Sharan Sams, Almog Levi, Assaf Malka, Natalia V. Bal, Alexander V. Maltsev, Evan Elliott, Abraham O. Samson · 2021 · Molecular Neurobiology
24. Lovastatin Differentially Regulates α7 and α4 Neuronal Nicotinic Acetylcholine Receptor Levels in Rat Hippocampal Neurons
    Virginia Borroni, Constanza B. Kamerbeek, María F. Pediconi, Francisco José Barrantes · 2020 · Molecules
25. Targeting Synaptic NMDA Receptor Co-agonism as a Therapy for Alzheimer’s Disease?
    Giles E. Hardingham · 2020 · Cell Metabolism
26. CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer’s Disease
    Posada-Duque, Rafael Andrés, Cardona-Gómez, Gloria Patricia · 2021 · Journal of Alzheimer's Disease
27. Protective effects of β‐sheet breaker α/β‐hybrid peptide against amyloid β‐induced neuronal apoptosis in vitro
    Sourav Kumar, Ashim Paul, Sourav Kalita, Anup K. Ghosh, Bhubaneswar Mandal, Amal Chandra Mondal · 2016 · Chemical Biology & Drug Design
28. Structure-Based Discovery of Dual-Target Hits for Acetylcholinesterase and the α7 Nicotinic Acetylcholine Receptors: In Silico Studies and In Vitro Confirmation
    Sebastian Oddsson, Natalia M. Kowal, Philip Kiær Ahring, Elín Soffia Ólafsdóttir, Thomas Balle · 2020 · Molecules
29. Combination therapy with cilostazol, aripiprazole, and donepezil protects neuronal cells from β-amyloid neurotoxicity through synergistically enhanced SIRT1 expression
    Hye Jin Heo, So Youn Park, Yi Sle Lee, Hwa Kyoung Shin, Ki Whan Hong, Chi Dae Kim · 2020 · Korean Journal of Physiology and Pharmacology
30. The potential role of nanoyttria in alleviating oxidative stress biomarkers: Implications for Alzheimer's disease therapy
    Kim San Tang · 2020 · Life Sciences
31. Inhibitor Kappa B Kinase β, Modulated by DJ-1/p-VHL, Reduces Phosphorylated Tau (p-Tau) Accumulation via Autophagy in Alzheimer’s Disease Model
    Weiping Chen, Ge Zhang, Zhijuan Cheng, Xunhu Gu, Min Li, Xu Liu · 2020 · Neuroscience
32. Probing the putative α7 nAChR/NMDAR complex in human and murine cortex and hippocampus: Different degrees of complex formation in healthy and Alzheimer brain tissue
    Mohamed R. Elnagar, Anne B. Walls, Gouda Kamel Helal, Farid M.A. Hamada, Morten Skøtt Thomsen, Anders A. Jensen · 2017 · PLoS ONE
33. Chronic administration of Tat-GluR23Y ameliorates cognitive dysfunction targeting CREB signaling in rats with amyloid beta neurotoxicity
    Fatemeh Ashourpour, Adele Jafari, Parvin Babaei · 2021 · Metabolic Brain Disease
34. Activators of α7 nAChR as Potential Therapeutics for Cognitive Impairment.
    Xiao-Hai Wang, I. M. Bell, Jason M. Uslaner · 2020 · Current topics in behavioral neurosciences
35. Concatenating plasma p-tau to Alzheimer’s disease
    Betty Marije Tijms, Charlotte Elisabeth Teunissen · 2020 · Brain
36. S100B gene polymorphisms are associated with the S100B level and Alzheimer’s disease risk by altering the miRNA binding capacity
    Jiafeng Wang, Yulan Zhou, Yixia Yang, Xiang Gao, Zhibin Liu, Guanhao Hong, Lifen Yao, Jingwen Yin, Xuefeng Gu, Keshen Li · 2021 · Aging
37. Calpastatin Mediates Development of Alzheimer’s Disease in Diabetes
    Lingyan Zhu, Li Gong, Tianlun Yang, Xiangwei Xiao · 2019 · Journal of Alzheimer s Disease
38. The optimization of a novel selective antagonist for human M2 muscarinic acetylcholine receptor
    Miaomiao Li, Chen Huang, Xingyu Wu, Fan Ding, Zhoumi Hu, Yan Zhu, Lan‐Xue Zhao, Lina Hou, Hongzhuan Chen, Hao Wang et al. · 2020 · Bioorganic & Medicinal Chemistry Letters
39. Impairment of Store-operated Calcium Entry: Implications in Alzheimer’s Neurodegeneration
    Jing Zhou, Shengzhou Wu · 2021 · Current Alzheimer Research